BioCentury
ARTICLE | Clinical News

Imetelstat: Interim Phase II data

September 19, 2016 7:00 AM UTC

Geron said the activity observed in the 4.7 mg/kg imetelstat arm does not warrant further investigation of the dose following an interim review of 12-week data from 40 patients with intermediate-2 or ...